Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults
- PMID: 36285199
- PMCID: PMC9549228
- DOI: 10.1177/15357597221107796
Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults
Comment on
-
Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study.Neurology. 2022 Jan 11;98(2):e125-e140. doi: 10.1212/WNL.0000000000013005. Epub 2021 Oct 21. Neurology. 2022. PMID: 34675100
References
-
- van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumors: Epidemiology, mechanisms, and management. Lancet Neurol. 2007;6:421-430. - PubMed
-
- Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996. - PubMed
-
- Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997-1003. - PubMed
